Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors
This study looks at a new way to diagnose certain cancers without needing surgery. It uses a special scan called PET/CT, which combines two types of imaging. The scan uses a substance called [18F]F/[68Ga]Ga-NOTA-T4 to help doctors see tumors in the pancreas, breast, or head and neck. This technique could help find and treat these cancers more easily and safely. The study focuses on adults aged 18 to 65 who already have colorectal cancer confirmed by tests and are willing to take part. However, people with severe liver or kidney issues or who had recent surgeries may not join.
- Participants must be between 18-65 years old.
- The study involves a noninvasive PET/CT scan.
- No major surgeries or other clinical trials recently.
The study might help by offering a clearer picture for diagnosing and deciding treatments for these cancers. 🏥
Study details
NCT06203574
Huashan Hospital
24 January 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.